title: Efficacy of admission screening for extended-spectrum beta-lactamase producing Enterobacteriaceae.
abstract: OBJECTIVE
  We hypothesized that admission screening for extended-spectrum β-lactamase-producing Enterobacteriaceae (ESBL-E) reduces the incidence of hospital-acquired ESBL-E clinical isolates.
  
  
  METHODS
  Retrospective cohort study.
  
  
  METHODS
  12 hospitals (6 screening and 6 non-screening) in Toronto, Canada.
  
  
  METHODS
  All adult inpatients with an ESBL-E positive culture collected from 2005-2009.
  
  
  METHODS
  Cases were defined as hospital-onset (HO) or community-onset (CO) if cultures were positive after or before 72 hours. Efficacy of screening in reducing HO-ESBL-E incidence was assessed with a negative binomial model adjusting for study year and CO-ESBL-E incidence. The accuracy of the HO-ESBL-E definition was assessed by re-classifying HO-ESBL-E cases as confirmed nosocomial (negative admission screen), probable nosocomial (no admission screen) or not nosocomial (positive admission screen) using data from the screening hospitals.
  
  
  RESULTS
  There were 2,088 ESBL-E positive patients and incidence of ESBL-E rose from 0.11 to 0.42 per 1,000 inpatient days between 2005 and 2009. CO-ESBL-E incidence was similar at screening and non-screening hospitals but screening hospitals had a lower incidence of HO-ESBL-E in all years. In the negative binomial model, screening was associated with a 49.1% reduction in HO-ESBL-E (p<0.001). A similar reduction was seen in the incidence of HO-ESBL-E bacteremia. When HO-ESBL-E cases were re-classified based on their admission screen result, 46.5% were positive on admission, 32.5% were confirmed as nosocomial and 21.0% were probable nosocomial cases.
  
  
  CONCLUSIONS
  Admission screening for ESBL-E is associated with a reduced incidence of HO-ESBL-E. Controlled, prospective studies of admission screening for ESBL-E should be a priority.
authors: Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada.
authors: Christopher F
authors: CF
authors: Lowe
authors: Kevin
authors: K
authors: Katz
authors: Allison J
authors: AJ
authors: McGeer
authors: Matthew P
authors: MP
authors: Muller
mesh_terms: D002170:Canada / Q000453:epidemiology; D017714:Community-Acquired Infections / Q000453:epidemiology / Q000382:microbiology; D003428:Cross Infection / Q000453:epidemiology / Q000382:microbiology; D004755:Enterobacteriaceae / Q000302:isolation & purification*; D004756:Enterobacteriaceae Infections / Q000453:epidemiology / Q000382:microbiology; D006761:Hospitals / Q000706:statistics & numerical data*; D006801:Humans; D015994:Incidence; D008403:Mass Screening; D010343:Patient Admission / Q000706:statistics & numerical data*; D012007:Rectum / Q000382:microbiology; D001618:beta-Lactamases / Q000096:biosynthesis*
chemical_list: D001618:beta-Lactamases
references: Infect Control Hosp Epidemiol. 2008 Jun;29(6):517-24
references: 18510461
references: Antimicrob Agents Chemother. 2012 Jul;56(7):3977-80
references: 22508296
references: J Infect Dis. 2002 Dec 15;186(12):1754-60
references: 12447761
references: Am J Infect Control. 2012 Nov;40(9):836-9
references: 22361360
references: Am J Infect Control. 2011 Sep;39(7):599-601
references: 21621295
references: Infect Control Hosp Epidemiol. 2010 Jun;31(6):620-6
references: 20370465
references: Drugs. 2010 Feb 12;70(3):313-33
references: 20166768
references: Clin Infect Dis. 2007 Nov 15;45(10):1347-50
references: 17968833
references: Am J Infect Control. 2007 Dec;35(10 Suppl 2):S165-93
references: 18068814
references: Lancet Infect Dis. 2008 Mar;8(3):159-66
references: 18291338
references: Clin Microbiol Infect. 2010 Feb;16(2):102-11
references: 20085604
references: Am J Infect Control. 2007 Mar;35(2):97-101
references: 17327188
references: Clin Infect Dis. 1999 Dec;29(6):1411-8
references: 10585788
references: Infect Control Hosp Epidemiol. 2003 May;24(5):362-86
references: 12785411
references: Clin Infect Dis. 2011 May;52 Suppl 5:S397-428
references: 21474585
references: J Hosp Infect. 2010 Oct;76(2):97-102
references: 20619929
references: Infect Control Hosp Epidemiol. 2011 Dec;32(12):1158-65
references: 22080653
references: Infect Control Hosp Epidemiol. 2010 Apr;31(4):330-7
references: 20175687